Maquet Cardiovascular recalled 32,867 units of the Heartstring III Proximal Seal System on August 15, 2025. Three failure modes can lead to inadequate hemostasis during procedures. Patients and healthcare providers must stop using this device immediately.
Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Maquet Cardiovascular, LLC or your healthcare provider for instructions. Notification method: Letter
The recall affects the Heartstring III Proximal Seal System, Model No. HSK-3038, with several serial numbers ranging from 3000377764 to 3000409172. These products were distributed worldwide, including the US and multiple other countries.
Three identified failure modes pose a high risk during medical procedures. These include failure to load the seal, failure to deploy into aortotomy, and failure to provide adequate hemostasis.
No specific incident counts are available. The hazards present a high risk of serious medical complications.
Stop using the device immediately. Contact Maquet Cardiovascular or your healthcare provider for further instructions and follow the recall instructions provided.
For more details, call Maquet Cardiovascular at 1-800-XXX-XXXX or visit their website. Additional information is available at the FDA's recall notification link.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.